Literature DB >> 6270226

Mast cell mediator release as a function of cyclic AMP-dependent protein kinase activation.

C M Winslow, R A Lewis, K F Austen.   

Abstract

Stereo-specific perturbation of the IgE-receptor (shown in previous studies) produces a monophasic rise in cyclic AMP that peaks at 15 s and a depletion of cyclic AMP-dependent protein kinase that plateaus at 30-60 s. The previously observed linear relationship between the attenuation in the monophasic rise in cyclic AMP and the quantity of mediator release in the presence of incremental concentrations of the adenosine analogue 2',5',-dideoxyadenosine, DDA, which is known to inhibit adenylate cyclase, indicated a direct relationship between receptor perturbation, transmembrane activation of adenylate cyclase, and granule secretion. The role of cyclic AMP as a second messenger in this sequence is now apparent from the linear relationship between net percent mediator release and net percent activation of cyclic AMP-dependent protein kinase isoenzyme when IgE-dependent activation of adenylate cyclase is suppressed by incremental quantities of DDA. There was a comparable percent activation of both types I and II mast cell cyclic AMP-dependent protein kinase isoenzymes with anti-IgE-induced activation and secretion, and there was a parallel suppression of the activation of both isoenzymes in the presence of DDA. Although these studies firmly link the activation of cytoplasmic cyclic AMP-dependent protein kinase to the IgE receptor-initiated transmembrane activation of adenylate cyclase. they do not discriminate among the functions of the two isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270226      PMCID: PMC2186495          DOI: 10.1084/jem.154.4.1125

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  On the question of translocation of heart cAMP-dependent protein kinase.

Authors:  S L Keely; J D Corbin; C R Park
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Dissociation and reassociation of the phosphorylated and nonphosphorylated forms of adenosine 3':5' -monophosphate-dependent protein kinase from bovine cardiac muscle.

Authors:  R Rangel-Aldao; O M Rosen
Journal:  J Biol Chem       Date:  1976-06-10       Impact factor: 5.157

3.  The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.

Authors:  J D Corbin; S L Keely; C R Park
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

4.  Ionic inhibition of catalytic phosphorylation of histone by bovine brain protein kinase.

Authors:  G W Moll; E T Kaiser
Journal:  J Biol Chem       Date:  1977-05-10       Impact factor: 5.157

5.  Correlation of protein kinase activation and testosterone production after stimulation of Leydig cells with luteinizing hormone.

Authors:  B A Cooke; M L Lindh; F H Janszen
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

6.  Isoproterenol injection alters protein kinase DEAE-cellulose profiles in selected rat tissues.

Authors:  R Roskoski; P Ngan; R Mettenburg; D D Lund
Journal:  Biochem Biophys Res Commun       Date:  1978-05-30       Impact factor: 3.575

7.  Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells.

Authors:  R A Lewis; S T Holgate; L J Roberts; J F Maguire; J A Oates; K F Austen
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

8.  Reconstitution of hormone-sensitive adenylate cyclase activity with resolved components of the enzyme.

Authors:  E M Ross; A C Howlett; K M Ferguson; A G Gilman
Journal:  J Biol Chem       Date:  1978-09-25       Impact factor: 5.157

9.  Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells.

Authors:  L B Schwartz; K F Austen; S I Wasserman
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

10.  Modulation of cyclic AMP in purified rat mast cells. III. Studies on the effects of concanavalin A and anti-IgE on cyclic AMP concentrations during histamine release.

Authors:  T J Sullivan; K L Parker; A Kulczycki; C W Parker
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

View more
  6 in total

Review 1.  Human mast cells and basophils--structure, function, pharmacology, and biochemistry.

Authors:  R P Schleimer; D W MacGlashan; E S Schulman; S P Peters; G K Adams; N F Adkinson; L M Lichtenstein
Journal:  Clin Rev Allergy       Date:  1983-09

2.  Crosslinking of the receptors for immunoglobulin E depolarizes the plasma membrane of rat basophilic leukemia cells.

Authors:  B I Kanner; H Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 3.  Mast cell and T cell communication; amplification and control of adaptive immunity.

Authors:  Alon Y Hershko; Juan Rivera
Journal:  Immunol Lett       Date:  2009-11-10       Impact factor: 3.685

4.  Thrombin-induced degranulation of cultured bone marrow-derived mast cells: effect on calcium uptake.

Authors:  R Pervin; B I Kanner; G Marx; E Razin
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

Review 5.  Transmembrane signalling and paf-acether biosynthesis.

Authors:  E Ninio; F Joly
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

6.  Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease.

Authors:  B Schick; K F Austen
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.